CFAP54

CFAP54 is a conserved structural component of the C1d projection of the central pair apparatus (CPA) in motile cilia and flagella, where it is required for proper C1d assembly and effective ciliary motility (PMID:26224312). Loss of CFAP54 in gene-trapped mice produces a specific ultrastructural defect of the C1d projection, decreased ciliary beat frequency, and perturbed cilia-driven flow, while leaving other ciliary structures intact (PMID:26224312). Its function is conserved with the Chlamydomonas homolog FAP54, and it operates as part of a C1d complex alongside CFAP221/PCDP1 that regulates flagellar motility in a calcium-dependent manner (PMID:26224312). Pathogenic loss-of-function and missense variants in CFAP54 cause primary ciliary dyskinesia in humans, and a knock-in mouse model recapitulates the disease phenotype of hydrocephalus, male infertility, and mucus accumulation (PMID:37725231, PMID:41393159). This CFAP54-associated PCD constitutes a distinct subtype defined by a defective C1d projection: affected individuals show normal situs, normal nasal nitric oxide, normal ciliary ultrastructure by TEM, and normal ciliary beating, yet exhibit insufficient ciliary transport — implicating CFAP54 in mucociliary clearance through C1d-dependent control of effective ciliary stroke rather than gross beat frequency (PMID:39362668).

1. 2015 High

   Established what CFAP54 does structurally by showing it is required to build the C1d projection of the central pair apparatus and that its loss impairs ciliary motility.

   Evidence Gene-trap loss-of-function mouse with TEM of cilia ultrastructure, ciliary beat frequency, and cilia-driven flow assays

   PMID:26224312

   Open questions at the time

   • Direct protein localization (e.g., immunofluorescence) to C1d not demonstrated
   • Biochemical interactions within the C1d complex not mapped
   • Molecular mechanism linking C1d defect to reduced beat frequency unresolved
2. 2015 Medium

   Placed CFAP54 in a conserved, calcium-responsive C1d complex by inferring its position from cross-species conservation with Chlamydomonas FAP54 and association with CFAP221/PCDP1.

   Evidence Comparative genomic expression analysis, TEM phenotyping in mouse mutants, and cross-species ortholog functional inference

   PMID:26224312

   Open questions at the time

   • Localization inferred from phenotype rather than direct imaging
   • Physical interaction with CFAP221/PCDP1 not biochemically demonstrated in mammals
   • Calcium-dependence inferred from ortholog, not directly tested for CFAP54
3. 2023 High

   Demonstrated CFAP54 is a disease gene by showing pathogenic variants cause human PCD and a knock-in mouse recapitulates the phenotype, linking loss of expression to disease.

   Evidence Whole-exome sequencing, minigene splicing assay, and knock-in mouse with PCD phenotype characterization

   PMID:37725231

   Open questions at the time

   • Protein-level consequences of variants not directly characterized
   • How reduced mRNA translates to C1d assembly failure not detailed
4. 2024 High

   Defined a distinct PCD subtype in which CFAP54 loss impairs ciliary transport despite normal ultrastructure, NO, and beating — refining the functional readout of C1d defects.

   Evidence High-throughput sequencing of C1d genes, in vitro ciliary transport assays, high-speed videomicroscopy, TEM, and nasal nitric oxide measurement in patients

   PMID:39362668

   Open questions at the time

   • Mechanism by which transport fails despite apparently normal beating is unresolved
   • Quantitative relationship between C1d defect and stroke efficiency not established
5. 2024 Medium

   Profiled the downstream cellular consequences of CFAP54 loss by mapping cell-type-specific transcriptional responses in mutant tracheal epithelium.

   Evidence Single-cell RNA sequencing of Cfap54 mutant mouse tracheal epithelial cells with differential expression analysis

   PMID:39558053

   Open questions at the time

   • Transcriptomic, not biochemical, characterization
   • Causal link between specific transcriptional changes and clearance defect not established
6. 2025 Medium

   Extended the pathogenic variant spectrum by demonstrating a splice variant causing exon skipping, frameshift, and loss of function.

   Evidence Minigene splicing assay, exome reanalysis, and ACMG/AMP classification

   PMID:41393159

   Open questions at the time

   • Single patient, single lab
   • Protein-level and ciliary consequences of this specific variant not directly assayed

• How CFAP54 physically assembles into the C1d projection and converts central-pair structure into effective ciliary stroke and transport remains undefined.
• No direct biochemical map of CFAP54 within the mammalian C1d complex
• No structural model of CFAP54 in the central pair
• Mechanism coupling C1d integrity to transport efficiency unknown